This suggests that in individuals with the Fads2 deletion allele, the high consumption of ALA may only have an attenuated beneficial effect on the prevalence of the metabolic syndrome, which demonstrates the influence of genetic variation in Fads2 on the mediation of disease risk. Here, FADS2 is linked to metabolic syndrome.